Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
August 26, 2019 - Eli Lilly announced the FDA approval of Taltz (ixekizumab), for the treatment of adult patients with active ankylosing spondylitis (AS).
Return to publications